Abstract The coronavirus disease 2019 (COVID-19) pandemic has disproportionately
affected patients with kidney disease, causing significant challenges in disease …

CoronaVac, also known as the Sinovac inactivated SARS-CoV-2 vaccine, has been widely
implemented in combating the COVID-19 pandemic. We summarized the results of clinical …

Rationale & Objective Patients with kidney failure who are receiving maintenance dialysis
have a higher risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS …

Results After the first vaccine dose, four of 22 (18%) patients on dialysis compared with 43 of
46 (93%) healthy controls developed positive anti-S1 IgG, with a median anti-S1 IgG index …

Background Patients with chronic kidney disease, dialysis patients and kidney transplant
patients are at high risk of develo** severe coronavirus disease 2019 (COVID-19). Data …

Background Humoral response against sudden acute respiratory syndrome coronavirus 2
(SARS-CoV-2) after two doses of BNT162b2 (Pfizer-BioNTech) has been proven to be less …

Background Patients undergoing in-centre haemodialysis (HD) are particularly exposed to
the dire consequences of COVID-19. The present systematic sco** review aims to identify …

A brief comprehensive overview is provided of the elements constituting the burden of
kidney disease [chronic kidney disease (CKD) and acute kidney injury]. This publication can …

Abstract Background Coronavirus Disease‐19 (COVID‐19) has high mortality in kidney
transplant recipients (KTR), and vaccination against severe acute respiratory syndrome …

Introduction It is unknown how the COVID-19 pandemic has affected the care of vulnerable
chronic hemodialysis (HD) patients across regions, particularly in low and lower-middle …